Skip to content
naulon
Not checkedNot checked for notices yet.

Diffusion-weighted MRI in liver fibrosis staging: Added value of normalized ADC using spleen and renal cortex as reference organs

Tamer F. Taha Ali, Mona AbdelGhaffar El Hariri

The Egyptian Journal of Radiology and Nuclear Medicine · 2017

doi:10.1016/j.ejrnm.2016.11.004 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Aim: To evaluate the potential value of the spleen and renal cortex as a reference organ to improve the performance of DWI in the assessment of liver fibrosis. Material and methods: 44 subjects were included: 30 patients with chronic viral hepatitis and 14 age matched volunteers. They were subjected to diffusion weighted MRI (DWI). Liver ADC, normalized ADC (ratio between ADC of liver to spleen (S-ADC) and renal cortex (R-ADC)) was calculated. Data was analyzed and ROC was used to evaluate the performance of ADC, S-ADC and R-ADC. Results: No significant difference between spleen ADC and renal ADC values between patient group and control group or in-betweens different fibrosis stages. The mean liver ADC was significantly lower in cirrhotic patients than control group (1.59 ± 0.024 versus 1.55 ± 0.036 × 10−3 mm2/s, P = 0.009) with some overlap in different fibrosis grades. With exception to stage 1 fibrosis, the mean S-ADC value was significantly lower in patients with different hepatic fibrosis stages in comparison to control group (P 0.02–<0.001). Significant negative correlation was noted between S-ADC value and fibrosis stage (r = −0.75, p < 0.001). It had significant difference between stage 0 compared to stage 2, 3, and 4 as well as between stage 4 in comparison to stage 1, 2 and 3. S-ADC had a significant ability to differentiate between stages 0–1 Vs stage 2–4, stage 0–2 Vs stage 3–4 as well as stage 0–3 Vs stage 4. Significant negative correlation was noted between R-ADC value and fibrosis stage (r = −0.68, p < 0.001). The mean R-ADC value was lower in patients with liver fibrosis compared to volunteers with significant difference between stage 0 and 3 and between stage 0 and 4 (P < 0.001). It had significant difference between stage 0 compared to stage 3, and 4 as well as in stage 4 in comparison to stage 1 and 2. R-ADC has a significant ability to differentiate between stages 0–1 Vs stage 2–4, stage 0–2 Vs stage 3–4 as well as stage 0–3 Vs stage 4. ROC analysis showed higher performance using S-ADC in comparison to liver ADC and R-ADC while R-ADC had higher performance in comparison to liver ADC. The AUC, sensitivity, specificity, PPV, NPV and k-value for detection of fibrotic stages ⩾2 (0.85, 95.8%, 60%, 74%, 92% and 0.85 for S-ADC Vs 0.68, 66.7%, 60%, 66%, 60% and 0.28 for ADC and 0.85, 95.8%, 50%, 69%, 91% and 0.47 for R-ADC). and in detection of fibrotic stages ⩾3 was (0.86, 100%, 52%, 61%, 100% and 0.48 for S-ADC Vs 0.63, 63%, 52%, 50%, 65% and 0.14 for ADC and 0.88, 100%, 44%, 57%, 100% and 0.40 for R-ADC) while for fibrosis stage 4, the corresponding values was (1, 100%, 100%, 100%, 100% and 1 for S-ADC Vs 0.7, 81%, 54%, 37%, 90% and 0.26 for ADC and 0.65, 100%, 65%, 45%, 100% and 0.43 for R-ADC) respectively. Conclusion: Normalized liver ADC using the spleen and kidney increases the performance of ADC in the evaluation of liver fibrosis which is highest in spleen normalized ADC.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.